Current Stem Cell Research & Therapy

Dr. Yoo is a Professor, Associate Director and Chief Scientific Officer at the Wake Forest Institute for Regenerative Medicine (WFIRM), and is cross-appointed to the Departments of Urology, Physiology and Pharmacology and Biomedical Engineering. Dr. Yoo's research efforts have been directed toward the clinical translation of tissue engineering technologies and cell-based therapies. Dr. Yoo's background in cell biology and medicine has facilitated the transfer of several cell-based technologies from the bench-top to the bedside. A few notable examples of successful clinical translation include the bladder, urethra, vagina, and muscle cell therapy for incontinence.

Prof. Dr. Lars-Peter Kamolz is currently working as a full professor and chair at the Medical University Graz (Clinical Division of Plastic, Aesthetic and Reconstructive Surgery) as the director of COREMED (Cooperative Centre for Regenerative Medicine) at JAONNEUM REASEARCH Forschungsgesellschaft mbH. He is the Deputy Chief Medical Officer at the University Hospital in Graz, and his research interests include Regenerative Medicine, Stem Cell Research, Tissue Engineering and Cell Induced Auto-Regeneration. He is serving as an editorial board member and reviewer in several international pubmed listed journals and author of more than 200 pubmed listed articles.

Dr. Liang Qiao is currently a principal research fellow and an Associate Professor in the Storr Liver Centre at the Westmead Institute for Medical Research, the University of Sydney. Dr. Qiao also serves as an editor for other international journals (Cancer Letters, World J Gastroenterol, Abdomen, Anti-Cancer Agents in Medicinal Chemistry, Anal Cell Pathol, etc.). He regularly reviews manuscripts for several international journals (Oncotarget, Int J Nanomed, J Hepatol, Stem Cell Dev, J Gastroenterol Hepatol, Liver International, etc). He is a member of the European Association for the Study of the Liver (EASL), a member of the Australian Society for Stem Cell Research (ASSCR).

Dr. Dario Siniscalco is working as a biochemist in the Department of Experimental Medicine of the University of Campania, Italy. He graduated in Chemistry from the University of Naples “Federico II” in 2000 and received his Ph.D. in Pharmacological Sciences from the Second University of Naples in 2004. before joining the Second University of Naples staff in 2006, he completed his neuropathology fellowship from the University of Alabama, Birmingham, USA. He is a registered member of a number of scientific societies including International Association of Neurorestoratology, Italian Pharmacological Society and Cell Death Research Group - University of Alabama at Birmingham, USA. He founded an international research group to study cellular and molecular changes in autism spectrum disorders. He is the author/co-author and reviewer of many articles having H index of 33. His main research interests are stem cells, gene expression and molecular regulation in autism spectrum disorders etc.

Professor Xiaosong Gu is the director of China National Ministry of Education and Jiangsu Key Lab of Neuroregeneration and is a member of the Chinese Academy of Engineering. He has led an active research team to make outstanding innovative achievements in the fields of tissue engineering and nerve regeneration. In brief, (1) tissue engineered nerve and nerve regeneration; (2) translation of tissue engineered nerve grafts to the clinic; (3) the regulatory roles and mechanisms of non-coding RNAs in peripheral nerve regeneration. Prof. Gu has published more than 100 academic articles in SCI-indexed journals, which includes Nature Communication, Brain, Progress in Neurobiology, Biomaterials, NAR and he also holds a number of Chinese and international invention patents.

Dr. Shi received his medical degree and Ph.D. at Third Military Medical University in Chongqing, China. His interest is broadly in radiation medicine and regenerative medicine, with a special focus on the research of stem cells for the management of severe difficult-to-heal traumatic injuries. He has published more than 110 peer-reviewed papers and filed 12 patents/inventions.

Dr. Marco TATULLO is Author/Co-Author of more than 100 scientific proceedings in Italian and European conferences and over 75 research articles (total IF>100; h-Index>20 on Scopus) in the last 8 years, published in international journals, indexed on PubMED, WoS and SCOPUS. Dr. TATULLO won 1st prize in “Robert Frank Award” Basic Research, Senior category in 2017 and, he was selected to represent CED-IADR in “Hatton award” competition during the recent general meeting in London on July 2018.

Prof. Massimo Conese received his Ph.D. in Cellular and Molecular Biology and Pathology from the University of Naples, Italy. During the Ph.D., he spent one year and a half at the Institute of Microbiology, University of Copenhagen, Denmark. Currently, Prof. Conese is Associate Professor in Pathology at the University of Foggia, Italy. Previously, he was Research Assistant at the Telethon Institute for Gene Therapy and Group Leader of the Institute for Experimental Treatment of Cystic Fibrosis, H. S. Raffaele, Milan, Italy. He has published more than 100 scientific publications and is co-author in 10 chapter books.

Prof. Michele Ammendola is a Researcher with National Qualification as Associate Professor at the Science of Health Department, “Magna Graecia” University of Catanzaro, Italy. In 2019, he became researcher of General Surgery in the Digestive Surgery Unit of “Mater Domini” University Hospital, “Magna Graecia” University. By attending the National Cancer Institute of Bari, Italy and the Department of Digestive Surgery, University Hospital of Strasbourg, France, he gained a lot of experience in oncological surgery. He is the author of many scientific articles published in International Journals with International Collaborations and a member of International Scientific Societies. His ongoing research interests involve the study of tumor microenvironment, particularly analyzing the role of immune stromal cells in neo-angiogenesis of gastrointestinal solid tumors. He is also developing a surgical patent with statistical validation of No-Coil Endorectal Tube placement in colorectal surgery for left hemicolectomy and low anterior resection without stoma.

Dr. Sveva Bollini graduated Summa Cum Laude from the University of Padova in Medical Biotechnology in 2005 and obtained her PhD from the same University in 2009 with a study on the regenerative potential of human amniotic fluid-derived progenitor cells for cardiac repair. From 2009 until 2013 she worked on the reactivation of endogenous mechanisms of cardiac regeneration as Post-Doctoral Research Associate first in the Molecular Medicine Unit, at the Institute of Child Health – University College of London and then in the Department of Physiology, Anatomy and Genetics of the University of Oxford, UK. In 2014, she was presented with the "Rita Levi Montalcini" Young Investigator Award from the Italian Ministry of Research and Education (MIUR) and invited back to Italy to study the cardio-active paracrine potential of the human amniotic fluid stem cell secretome to enhance cardiac repair. Currently, she serves as Associate Professor in Experimental Biology in the Department of Experimental Medicine (DIMES), University of Genova in Genova, Italy. Her research mainly focuses on the functional characterization of human fetal and perinatal stem cell extracellular vesicles to enhance mechanisms of cardioprotection following ischemic and cardiotoxic injury and to rejuvenate myocardial renewal.

Dr. Roberto Crocchiolo graduated in Hematology. He has been working for years in hematopoietic stem cell transplantation with focus on clinical and translational research on post-transplant infectious and immunological complications. Currently his main research activity applies to the field of histocompatibility and transplantation, by attempting to optimize the immunological tolerance between recipient and his/her donor, with the ultimate goal of improving the patient's prognosis.

Professor Aflredo Gorio, PhD, is a Professor of Medical Pharmacology, University of Milan, Italy. Dr. Gorio is also a member of the National Committee of Spinal Cord Injuries and Director of the Scientific Committee. He is head of the Multi-specialized Study Group in basic and clinical research on rare diseases, such as tuberous sclerosis (Bournonville Disease), and lymphangioleiomyomatosis or sporadic pulmonary LAM at hospitals in San Paolo and Humanitas. Dr. Gorio was a brilliant high school and university student in Milan, Italy, where he obtained the highest marks and awards. In 1974, he joined the Rockefeller University in New York, NY, United States. He worked alongside Dr. Phil Siekevitz, the pioneer of the neuromuscular junction and was awarded the Postdoctoral Research Award for Muscular Dystrophy (1976-1978). He has worked at the University of Milan since 1989. Recognized by his peers as one of the world's pioneers in regeneration of nerves in the 1980s, he focused his research on peripheral neuropathies and neuromuscular transmission. His scientific interest also focused on neuronal degeneration, the role played by diabetes, and the events leading to the secondary regeneration process for acute Central Nervous System (CNS) lesions. Recently, Dr. Gorio has identified erythopoietin (EPO) as a neuroprotective agent in acute traumatic lesions of the spinal cord. These reports and the rapid development of the scientific literature led to a wave of clinical studies of human patients suffering from either CNS or spinal cord lesions. Dr. Gorio's team is also at the forefront in the purification and study of neural precursor cells (NPC) and their possible role in spinal cord injuries (SCI). More recently, A Gorio described a new type of NPC, which, collected 6 hours after death, is able to survive in the adverse environment of a traumatic spinal cord injury. Their differentiation gives a much higher percentage of neurons and this is due to the release of EPO and its action. Preliminary results suggest that these cells may represent a more effective approach to the treatment of CNS degenerative diseases. In this context, he has been describing the novel activities of mechanically activated adipose tissue for treating peripheral tissues inflammation and spinal cord injury. Professor Gorio is the author of over 500 scientific publications and editor of 11 books devoted to neural regeneration.

Dr. Roberto Gramignoli’s primary interest has always been to investigate new, advanced cellular treatments for acute or congenital liver disorders. His group successfully proposed solutions for the advancement of hepatocyte transplant as a bridge or alternative therapy to orthotopic liver transplantation. It was established that the main limiting factor in hepatocyte transplant is the availability of useful cells. Dr. Gramignoli focused his energy to identify alternative sources for mature and functional hepatocytes, such as cells isolated from non-heart beating donors, or explanted liver tissues, or fetal and neonatal hepatic progenitors, with greatest results obtained by transplantation of perinatal amnion epithelial cells. All the validated cell sources have been successfully translated into clinical programs.

Dr. Kai Jiao is the director of the Department of Oral Medicine in Stomatology Hospital of the Fourth Military Medical University. He is mainly engaged in the research of the pathogenesis and therapeutic targets of bone disease, such as osteoarthritis and bone defect. He has published 52 scientific papers as the first or corresponding author, including Advance Materials, Advance Functional Materials, Science Advance, Advance Science, Biomaterials, et al. He got the Distinguished Young Investigator in Shaanxi Province, the first prize of science and technology progress of Shaanxi Province, the science and technology innovation team of Shaanxi Province, the excellent academic paper of natural science of Shaanxi Province in 2017 and 2020. He has 13 authorized patents to his credit and has published 4 monographs. He is a member of the senior committees in the Chinese Stomatological Association of Oral Biology.

Professor Jin is the director of Beijing Institute of Ophthalmology, full professor of Capital Medical University (CMU) and chief physician at Beijing Tongren Hospital, CMU. Using the state-of-the art technology of pluripotent stem cells, he focuses on stem cell translational medicine in retinal health and genetic mechanisms of ocular diseases. His team is dedicated to make efforts on elucidating the disease mechanisms of inherited retinal degeneration and children ocular disorders, translating laboratory technology to improve bedside outcome, and solving key basic & clinical questions. He has published over 120 peer-reviewed publications, including PNAS, Nat Commun, Sci Adv etc.

Dr. Li completed his Ph.D. at Mount Sinai Sch. Medicine, postdoctoral at Whitehead Inst./MIT, and fellowship at Harvard. His research consists of cancer stem cell; iPSC; brain tumor; ex vivo, in vitro, in vivo model; cancer genome, single-cell transcriptome; tumor microenvironment. He taught as adjunct professor at CSUF and at CSUCI. He serves on editorial board of Am. J. Pathol., Curr. Stem Cell Res. and Ther., World J. Stem Cells (Editor-in-Chief), PLOS ONE (Academic Editor), Quantitative imaging in medicine and surgery, Cells (Switzerland), and with membership of ACTS, ISSCR, SfN, ASCB, ASIP, and Royal Society of Medicine (elected overseas fellow).

Rei Ogawa has the M.D. and Ph.D. degrees. He is currently a faculty member at the Nippon Medical School in Tokyo, Japan, with a position of Professor and Chief at the Department of Plastic, Reconstructive, and Aesthetic Surgery. Also, he is a visiting lecturer at Tokyo University from 2013. He is a fellow of American College of Surgeons (ACS) and a member of American Association of Plastic Surgeons (AAPS). In addition, he is now directing the Mechanobiology and Mechanotherapy Laboratory at his medical school. He joined the Tissue Engineering and Wound Healing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA, where he worked between 2007 and 2009 as a Research Fellow. He has focused his recent studies on mechanobiology and its application to tissue engineering, wound healing and anti-aging medicine.

Dr. Assunta Pandolfi is a professor of Laboratory Medicine at the G. d’Annunzio University (Chieti, Italy). She holds a Biological Science degree (Mario Negri Institute, Milan) and a PhD in Physiopathology of Metabolism (Universities of Chieti and Rome). In 1986, she moved to the Cardiovascular Laboratory in Mario Negri Institute (Milan) and in 1988, she won a fellowship at the Consorzio Mario Negri Sud (Chieti) as a researcher. In 2007, she was appointed as associate professor of Laboratory Medicine at the G. d’Annunzio University where, since August 2020, she is a professor of Laboratory Medicine.

Lia Patsavoudi completed her doctorate thesis at the College de France and received her doctoral degree in Animal Physiology from the University P.et M. Curie (Universite Paris VI). She was a researcher at the Hellenic Pasteur Institute and is currently a professor of Biology and Human Physiology at the University of West Attica in Athens Greece. Since 1991, her research interests, as a group leader, involved the study of proteins implicated in cell motility processes during health and disease with particular emphasis during the last 15 years, on the role of heat shock proteins in cancer cell development and metastasis.

Dr. Petrella Francesco is an Associate Professor of Thoracic Surgery at the Department of Oncology and Hemato-Oncology of the University of Milan and Deputy Director at the Division of Thoracic Surgery of the European Institute of Oncology, Milan, Italy. He received his PhD degree in Regenerative Medicine from the University of Padua, Italy. His current research interests are thoracic surgical oncology, regenerative medicine and stem cell technology applied to surgery. His clinical interests focus on locally-advanced resectable lung cancer and mediastinal tumors, chest wall surgery, malignant mesothelioma and ECMO-assisted general thoracic surgery. He is also an Associate Editor of “The European Journal of Cancer Prevention” and “Frontiers in Oncology” (Thoracic Oncology) and also serves as editorial board member of “Cancers”, “Journal of Thoracic Disease”, “Frontiers in Surgery” and “Open Medicine”.

Dr. Caterina Pipino completed her Ph.D. in Biomedical Sciences at University G. d’Annunzio of Chieti and UCL of London and a postdoctoral fellowship at Harvard Medical School of Boston. She is currently working as Assistant Professor in the laboratory of Vascular and Stem Cell Biology at University G. d’Annunzio of Chieti. Her special interests are stem cell and regenerative medicine; in vitro models; bone regenerative medicine; vascular biology; cardiovascular disease; bioactive molecules. She serves on the editorial board of Stem Cell and Translational Investigation, Stem Cell Research and Therapeutics etc and she is Topic Editor of Clinical Cytology, Journal of Clinical Medicine and also is a reviewer of several internationally reputed journals including Stem Cell and Development, Acta Histochemica etc.

Dr. Silva, is a Professor at the Federal University of Santa Catarina. He is coordinating the Stem Cell and Bioengineering Laboratory at the Department of Cell Biology, Embryology and Genetics. He holds a Bachelor of Science degree in Pharmacy in 1989, the Master degree in 1992 and the Ph.D. degree in 1995 in Sciences. His laboratory investigates the therapeutic role of placenta-derived mesenchymal stem cells (MSCs), obtained from healthy donors at the Hospital of the Federal University of Santa Catarina (HU/UFSC, Brazil).

Hossein Baharvand is a distinguished Professor and Director of Royan Institute for Stem Cell Biology and Technology. He has focused his research interests on improving the translational research and regenerative medicine mainly through the understanding of Stem Cells and Developmental Biology and Biologically inspired Engineering. He is the editor of four international books. He has published 265 international peer-reviewed papers, as well as seven chapters in international books. As of Sep 2016, Google Scholar reports over 5600 citations and h-index 40 to his work. He has received 29 international and national awards including the United Nations Educational, Scientific and Cultural Organization (UNESCO)-Equatorial Guinea international prize (2014) for research in life sciences aimed at improving the quality of human life with his stem cell research and its numerous applications in regenerative medicine.

Dr. Karen Ballen is the Cancer Center Distinguished Professor of Medicine at the University of Virginia in Charlottesville, VA and the Section Chief for Hematology, Stem Cell Transplant, and Hematologic Malignancy at the University of Virginia Health System. She was graduated from Harvard College and Dartmouth Medical School. Her career has been devoted to the care of patients with leukemia and patients needing stem cell transplantation. Her clinical research expertise is in umbilical cord blood transplantation and outcome results. She has published over 150 papers on this topic. She is the Chairman of the Cord Blood Advisory Committee of the National Marrow Donor Program, and serves on the Advisory Board of the Center for International Blood and Marrow Transplant Research. She is Associate Editor of the journal Bone Marrow Transplantation and Lead Editor for Stem Cells Translational Medicine.

Dr. Carvalho is a Medical Doctor, Neurologist and Pediatrician at the University of São Paulo, Brazil. she did specialisation in biology, pathology and neuromuscular development, Université Paris VII and Pitié Salpêtrière Hospital, France, PhD in 1988 to 1990); Master of Science (MsC) in Neurology, USP (1994) and second PhD in Bioprocess and biotechnology in Health Science from the Federal University of Paraná, Brazil (2006). From 2001 to 2008, she was the head of the Experimental Preclinical Laboratory Research on stem cell therapy and translation at the Pontifical Catholic University of Paraná. Since 2006, she is the head of the “Cell Therapy and Biotechnology in Regenerative Medicine” Research Group, particularly in Neurodegenerative Diseases at the Pelé Pequeno Príncipe Institute, Curitiba, Paraná, Brazil. She is a Professor of Pequeno Príncipe College, and supervisor of Bachelor, Master and Doctoral Theses. She is the editor and author of a patent.

En-Qiang Chen received a doctor degree in Clinical Medicine from Sichuan University of China (2012) and completed the physician training of both general internal medicine and hepatology in West China Hospital of Sichuan University. At present, En-Qiang Chen is appointed associate professor at Infectious Diseases Center of West China Hospital. Over the last 10 years, En-Qiang Chen has focused his scientific interests on the topics related to Stem cell therapy for liver diseases as well as the pathogenesis and new strategies for the treatment of liver disease.

Isotta Chimenti is Researcher/Assistant Professor at the Department of Medical Surgical Sciences and Biotechnologies, and Junior Fellow of the Superior School for Advanced Studies at “La Sapienza” University of Rome. She is MS in Medical Biotechnology and PhD in Experimental Medicine. She has been a postdoc fellow at Johns Hopkins University, Cedars Sinai Heart Institute, and at Pasteur Institute – Italy. Her research activity is focused on cardiac cell therapy and cardiac tissue engineering, adult stem cells, mechano-sensing, and oxidative stress in the cardiovascular system. She is funded as PI by several Italian National grants, and participant in a European Horizon 2020 project. She co-authored 50 Scopus indexed publications.

Professor Marc H. Dahlke is a lecturer for experimental surgery at Regensburg University, Germany. He is also an attending surgeon at Regensburg University Medical Center. Dr Dahlke has received his MD degree from Hannover Medical School in 2002 and his PhD degree from the same institution in 2004 after graduating from the MD/PhD program for molecular medicine. He has received specialty training in surgery as a fellow at the University of Sydney (Australia) and at Memorial Sloan Kettering Cancer Center in New York, USA.

Dr. Datta is an Associate Professor at the Department of Chemistry & Biochemistry, Kent State University. He obtained his doctorate (Ph.D.) in Chemistry from University of Nebraska at Lincoln and Post-doctoral experience from Yale University School of Medicine. Dr. Datta works on tumor suppressor protein, p67 and has published more than 50 research articles. Dr. Datta teaches two semester Biochemistry courses for senior undergraduate and graduate students.

Dr. Win-Ping Deng is the Deputy Dean and Distinguished University Professor at College of Oral Medicine, Taipei Medical University (TMU) Taiwan. He obtained his doctorate from Harvard University USA in 1993. In 2000, Dr. Deng joined the Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University (TMU) Taiwan as a Director, where he established and directed the Stem Cell Research Center. Dr. Deng research focuses on cell therapy and regenerative medicine for treatment of oral, musculoskeletal and cancer disorders. Owing to his outstanding research accomplishments, he is also honored with editorial board membership of the prestigious journal Biomaterials by Elsevier.

Mohammadreza Baghaban Eslaminejad earned his PhD from Tarbiat Modares University, Tehran, Iran and joined Royan Institute in 2004. He founded the adult stem cell lab and started his research on mesenchymal stem cells. The aim of this lab was to utilize stem cells for treatment of orthopedic diseases, especially bone and cartilage defects. He has done research on various animal models such as mouse, rabbit and dog, the result of which has been published in 180 papers and 190 abstracts in national and international journals and conferences. Moreover, he has contributed in 15 international books.

Dr. Michael Franti is working as a Director (Regenerative Medicine) at Boehringer Ingelheim, Ridgefield, CT, US. He has over 14 years of pharmaceutical industry experience and 3 years of post-doctoral experience. Currently, he is in charge of the global Regenerative Medicine strategy portfolio. Dr. Franti obtained his PhD (Molecular Virology) in 2001 from University of Pierre and Marie, Paris, France. He has around 34 scientific publications to his credit.

R. Gangaraju received a Ph.D. in Molecular Biology with a wealth of experience in preclinical pharmacology, animal model development and drug discovery with specific training and expertise in key research areas including signal transduction pathways in mesenchymal stem cells and endothelial cells. His laboratory focuses on the neurovascular unit (NVU) of the retina in health and disease. They primarily utilize preclinical in vitro and in vivo models to investigate the potential of their findings for clinical translation, with the long-term goal of advancing the clinical management of diabetic retinopathy, age-related macular degeneration and visual deficits of traumatic brain injury. He serves as the Chairman of the Scientific Advisory Board. His successful collaborations led to several peer-reviewed publications, conference abstracts and patent applications for each project. He also served as the reviewer of several biomedical journals and grant agencies including UK Diabetes and DoD.

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He received his Ph.D. in biology from the University of Cambridge. His research interests encompass the characterisation of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism (“damage”) that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.

Prof. Wolf-Dieter Grimm is a Clinical Periodontist who graduated from dentistry, Pavlov First State Medical University of St. Petersburg in 1968. He worked for Technical University Dresden, for Academy of Postgraduate Programs in Dentistry Schwerin, and for University of Witten/Herdecke, Periodontology, Department of Dental Medicine, Faculty of Health, Germany, 1991 to date as chair of Periodontology and now as emeritus. Prof. Grimm has developed several methods for Minimal-invasive and Regenerative Periodontology. Prof. Grimm is Diplomate of Periodontology® (German Society of Periodontology/European Federation of Periodontology). His current stem cell research is focused on adult (somatic) stem cells and the regulation of their fundamental biological properties including differentiation, proliferation, and migration. He is further interested in the impact of pro- and anti-inflammatory signals on mesenchymal stem cells (progenitor of bone, fat and cartilage tissues) and in neural crest-derived stem cells within the head region.

Jerome Guicheux, PhD-D.Sc., INSERM research director/professor JG is the co-director of the INSERM lab U791 (Nantes, France). JG is the elected president of the French Society for mineralized tissue biology and the national coordinator of the French osteoarthritis network. He is author or coauthor of 140 international publications (h-index 42), 8 patents and 71 invited lectures. His research activities focus on the development, pathophysiology and regenerative medicine of the skeleton with particular attention to stem cells and biomaterials for the repair of cartilage and intervertebral disc.

Dr. Harris is a graduate of Wake Forest University where he obtained BS in Biology, Mathematics and Psychology. He earned his Doctorate in Microbiology and Immunology in 1982. In 1989 Dr. Harris joined the faculty at the University of Arizona in the Department of Immunology. Dr. Harris established the first cord blood bank in 1992. He currently serves as the Executive Director of the University of Arizona Biorepository, as well as Director of Quality at the GMP Laboratory. His research interests include stem cells and regenerative medicine.

Dr. Jinesh completed his PhD in Biotechnology at Rajiv Gandhi Centre for Biotechnology, Trivandrum, India, with deep interests in studying cancer cell biology. He had undergone post-doctoral trainings at Weizmann Institute of Science, Israel and at University of Texas MD Anderson Cancer Center, Houston, TX, USA where he discovered blebbishield emergency program which helps the cancer stem cells to undergo cellular transformation after commitment of apoptosis to evade genomic instability and immune phagocytosis checkpoints and to exhibit enhanced glycolysis, tumorigenesis and metastasis. Dr. Jinesh has multiple first authored cell biology publications and has deep interests in drug discovery, cancer stem cell biology, genomics, and immunology. He is currently a research scientist at H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.

Dr. Ji Hyun Kim is an Instructor at the Wake Forest Institute for Regenerative Medicine (WFIRM). Dr. Kim's research efforts in the tissue engineering and regenerative medicine address shortage of transplantable organs by providing functional engineered tissues in a clinically relevant manner. Dr. Kim has focused on establishing novel strategies to efficiently restore tissue function for treating critical size defects using tissue-engineering technologies and cell-based therapies. Dr. Kim is particularly interested in the fields of designing 3D microenvironment for tissue engineering applications, 3D bioprinting biomimetic tissues or organs for functional repair, repair of clinical-scaled tissue injury through efficient delivery of cells, in vivo organogenesis and in situ tissue regeneration.

Dr. Zaal Kokaia obtained a doctorate (Ph.D.) in neuroscience from the University of Lund, Sweden. Dr. Kokaia also holds PhD in neurophysiology from Beritashvili Institute of Physiology, Tbilisi, Georgia. Currently, Dr. Kokaia is the Professor of Experimental Medial Research at Lund University, Sweden. He is also the Director of Lund Stem Cell Center and heads the Laboratory of Stem Cells and Restorative Neurology. He coordinates Strategic Research Area in Stem Cells and Regenerative Medicine (Stem Therapy) at Lund University supported by Swedish Government. His research interests are generation and characterization of neural stem cell lines from different sources and through reprogramming and development of stem cell-based treatments for stroke.

Dr. Kumar is working as senior scientist at ICAR-Central Institute for Research on Buffaloes, Hisar, Haryana, India. He obtained his MVSc and PhD in Animal Biotechnology from ICAR- NDRI, Karnal, India where he established simple and defined media for improved production of buffalo embryos, method for isolation of inner cell mass from blastocysts for derivation of embryonic stem cells, procedures for differentiation of ESCs to neurogenic and myogenic lineages and produced India’s first handmade cloned buffalo calf in 2009. During his post- doctoral fellowship at Institute of Farm Animal Genetics, Neustadt, Germany, generated iPS cells using transposon mediated reprogramming of fibroblasts and differentiated these cells into eye lens specific lineage. Currently, he is working on buffalo cloning to multiply superior bulls to meet the demand of semen for breed improvement. A total of 10 cloned bulls have been produced in which 7 are from single animal.

Dr. Li obtained his PhD at Mount Sinai School of Medicine, postdoctoral at Whitehead Institute of Massachusetts Institute of Technology, fellowship at Harvard Medical School. He is Principal Investigator at CHOC Children’s Hospital and University of California-Irvine School of Medicine and adjunct professor of California State University Fullerton and Sun Yat-sen University. He has over 148 publications including the peer-reviewed articles and 25 U.S.issued patents, as remarked in Nature, Science, Cell, Annual Reviews of Cell and Developmental Biology, with citations of 7,000+. He serves on editorial board of American Journal of Pathology (2008-) and he is a member of ACTS, ISSCR, SfN, ASCB, ASN, ASIP societies.

Dr. Modo is an Associate Professor in the Department of Radiology and Bioengineering at the University of Pittsburgh, USA. Prior to joining the University of Pittsburgh in 2011, he was a Senior Lecturer at the Institute of Psychiatry, King’s College London, where he also obtained his PhD in neuroscience. His main interest lies in repairing the stroke-damaged brain, foremost by employing neural stem cells, but also more recently using biomaterials. To visualize the repair process, Dr Modo employs non-invasive imaging, such as magnetic resonance imaging. In 2013, Dr Modo received the Bernard Sanberg Memorial Award for Brain Repair by the American Society for Neural Transplantation and Repair.

Dr. Mony received his Ph.D (Haematology) from The University of Nottingham, UK. He received prestigious awards such as Overseas Research Scholarship and Developing Solutions Scholarship (University of Nottingham, UK). He was also a recipient of the British Association of Cancer Research student award during his Ph.D time. He had his postdoctoral training as a senior fellow in a collaborative research programme at Memorial Sloan-Kettering Cancer Centre, USA, and Broad Institute of MIT and Harvard, USA. His expertise and training includes hemato-oncology, tumor microenvironment, preclinical drug discovery (small molecules), pre-clinical mice model development of cancers, and induced pluripotent stem cells (iPSC). He is trained and certified in rodent major surgical procedures from Cornell University, USA, and Memorial Sloan-Kettering Cancer Center, USA. He got trained in iPSC generation and differentiation from The University of Queensland and Monash University, Australia.

Dr. Takehiko Mori is an Associate Professor of Division of Hematology at Keio University School of Medicine in Tokyo, Japan.

Dr. Mori graduated from Keio University School of Medicine in Tokyo, Japan, in 1993. He completed a Postgraduate course of Internal Medicine (Hematology) at Keio University School of Medicine in 1997. Prior to his current roles, he was an Assistant Professor of Division of Hematology at Keio University School of Medicine.

Dr Mori’s specialties are hematological disorders and malignancies, hematopoietic stem cell transplantation, opportunistic infection and hospital infection control.

Dr. Muench received his doctorate (Ph.D.) in Cell Biology & Genetics from the Joan and Sanford I. Weill Medical College of Cornell University. He also obtained a B.S. degree in Genetics from the University of California at Davis and an A.S. degree in Physical Sciences from the College of Marin. Currently, Dr. Muench is a Senior Scientist at Blood Systems Research Institute in San Francisco and an Adjunct Associate Professor in the Department of Laboratory Medicine at the University of California San Francisco. Dr. Muench has published over 100 peer-reviewed papers, review articles and book chapters.

Danièle Noël is currently research director in the Inserm Institute for Regenerative Medicine and Biotherapies in Montpellier. She received her Ph.D. in Health Biology from the Bordeaux University in 1992. She did a post-doc in the Institute of Molecular Genetics in Montpellier in the field of recombinant retrovirology and gene therapy (1992-1999). She then moved to the Inserm u475 in Montpellier to work in cell therapy and obtained a permanent position in 2007. She became professor in 2011. Her main interests are mesenchymal stem cells and their applications in the treatment of osteo-articular diseases.

Professor Helen C. O’Neill is currently Director of the Clem Jones Research Centre for Regenerative Medicine at Bond University on the Gold Coast in Australia, where she holds a Chair in Immunology and Stem Cell Biology. Previously Professor O’Neill was Head of the Stem Cell and Immunology Laboratory at the Australian National University where she held an academic position for over 30 years. Early in her career she was twice a Visiting Fellow in the Weissman Laboratory at Stanford University. The overall theme of her work is the development of strategies for stem cell-based immunotherapy and regenerative medicine.

Dr. Rajarshi Pal is currently working as the Chief Scientist, Eyestem Research, a biotechnology start-up incubated at Centre for Cellular and Molecular Platforms (CCAMP), NCBS-TIFR Campus, Bangalore. He is also associated with TransDisciplinary University, Bangalore as Visiting Professor. From 2010-2017 he was engaged with the School of Regenerative Medicine, Manipal University as Assistant Professor and Principal Investigator of the ‘Stem Cells in Disease and Development” Group. Previously, he worked in National Institute of Immunology, New Delhi; Reliance Life Sciences, Mumbai and Stempeutics Research, Kuala Lumpur, Malaysia. Dr. Pal has 43 publications in peer-reviewed journals of high international repute; has 5 patents to his credit and has contributed 7 book chapters.

Dr. Manash Kumar Paul, currently working as Project Scientist at University of California Los Angeles (UCLA). He has contributed significantly in the field of stem cell biology, regenerative medicine and lung cancer. His research focused on various signaling process involved in maintaining stem cell homeostasis during injury and repair. Recently his group published, first in vitro method for the development of lung organoids mimicking lung from iPSCs. Dr. Paul has published in more than 20 peer reviewed international journals and his work has been highly cited. Dr. Paul is recipient of many awards that include prestigious UCLA Vice Chancellor’s Postdoctoral award and was nominated for Paul Boyer’s award. Dr. Paul is a member of many scientific societies (ISSCR, AHA, ALA) and editorial member of many international journals.

Dr. Pelacho is Researcher at the Center for Applied Medicine Research (CIMA) and Assistant Professor at the University of Navarra (Spain). She has more than 10 years of experience in research and development of novel therapies aimed to treat cardiovascular diseases. Previously, Dr. Pelacho performed a post-doctoral stay at the University of Minnesota (Stem Cell Institute), developing studies focused on the application of stem cell therapy for the treatment of myocardial infarction. During her career at the University of Navarra, she obtained a Ph.D. in Biochemistry. Dr. Pelacho has authored more than 40 manuscripts and has obtained several national and international grants as principal investigator.

Dr. Song is a Professor of Biomedical Engineering at Chongqing University, China. He received PhD degree from Chongqing University, China, and was awarded a Postdoctoral Fellowship for Foreign Researchers by the Japan Society for the Promotion of Science (JSPS) and took the postdoctoral training at Tohoku University and Nagoya University, Japan. Dr. Song’s research interests focus on exploring the mechanisms of stem cell mechanobiology regulated by various mechanical, chemical or coupled mechano-chemical factors. Dr. Song holds several patents and has published more than 100 international peer-reviewed papers, as well as two chapters in books. He also serves as a committee member for Chinese Society of Biomedical Engineering.

Dr. Kedong Song is currently Professor in Dalian R&D Centre for Stem Cells and Tissue Engineering, State Key Lab of Fine Chemicals, Dalian University of Technology. Prof. Song obtained a PhD degree from Dalian University of Technology. He was a Post‐doctoral research associate in Department of Chemical Engineering, Imperial College London from 2008 to 2009. He became a full professor in 2016 at Dalian University of Technology in the areas of 3D tumor models, Stem Cells, Tissue Engineering and Pharmaceutical Chemistry. Prof. Song has published over 100 papers on international journals, and has got citation more than 2,500 times.

Dr. Liling Tang is the professor of Biomedical engineering at the Chongqing University in China. She was graduated from Chongqing University in 2002. She worked as visiting scholar at University of California at Berkeley, the University of Hong Kong, and University of California at San Diego for several years. Her research focused on Molecular and cellular functions of mesenchymal stem cells and their applications in therapy, alternative splicing of genes in cells responding to signals, and developments of techniques and medicines used in cancer therapy. She has published over 100 articles.

Dr. Yaohui Tang received his Ph.D. degree from Shanghai Jiao Tong University in 2014. After graduation, he worked as a postdoc at Max-Planck-Institute for biological cybernetics in Germany and Stanford University in U.S. In 2018 he was recruited as a tenure-track assistant professor in School of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University. Dr. Tang has a broad interest in stem cell and gene-based therapy for ischemic stroke and tissue engineering. His work has been published on Stroke, JCBFM, AFM, etc, with more than 1000 citations and H-index=16. His work has been supported by national NSFC and SJTU Integration of Medical.

Dr. Marco Tatullo is the Scientific Director of “Tecnologica Research Institute”. Dr. Marco Tatullo is Medicine Doctor (MD) and Doctor in Dental Sciences (DDS) , PhD in “Medical Biochemistry, Medical Biology and Physics” . International collaborator of “Institut de Biologie Paris-Seine” (IBPS) France. Visiting Professor at the University “City Unity College” of Athens and at the “Bithai dental and medical college” in Pakistan. Author of over 70 publications in international journals. Editor in Chief of the book “Mesenchymal Stem Cells and Innovative Biomaterials in Dentistry" published with Springer-Nature. Committee Member for BIODEVICES international conference and past-Chair in T.E.R.M.I.S. symposium.

Dr. Wang is a distinguished Professor and Deputy Dean. He received his medical training at the Fourth Military Medical University, Xi’an, where he also earned a PhD degree, studying mechanisms of human intervertebral disc degeneration. Afterwards, he completed his fellowship from the University of Hong Kong and Princess Alexandra Hospital, Brisbane, Australia. As a principal investigator, he obtained 3 projects from the National Natural Science Foundation of China (NSFC) and 16 patents. He actively contributed to the medical community as reviewer of 25 journals with highly-cited guest- edited issues and evaluation expert for NSFC, by leading his studying team.

Dr. Yazhou Wang obtained his Ph.D. in neuroscience from Fourth Military Medical University and got postdoctoral training from the University of California at Davis. He is now an associate professor in the department of Neurobiology of the Fourth Military Medical University in China. His research is mainly on the mechanism of neural stem cell activation and adult neurogenesis. He has published 35 peer reviewed papers and served as reviewers for many journals. He is the one who first raised the concept of “quiescent/active neural stem cells”.

Prof Junjie XIAO is the Director of Institute of Cardiovascular Sciences in Shanghai University and the Vice Dean of School of Life Sciences, Shanghai University. He is the Associate Editor of Journal of Cardiovascular Translational Research, Editorial Board of BMC Medicine, and Editorial Board of Cell Transplantation. His major research interest is heart failure, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating heart failure.

Chunhui Xu, Ph.D., is an Associate Professor in the Department of Pediatrics, Emory University School of Medicine. Dr. Xu has extensive research experience on stem cells and cardiogenesis. Her research is focusing on cardiomyocytes derived from human pluripotent stem cells (hPSCs), which hold promise for cardiac cell therapy, disease modeling, drug discovery, and the study of developmental biology. Her group has made significant contribution to the field of pluripotent stem cells. Several of their publications have been identified as a hot paper or among the most highly cited publications in the field of hPSCs. She is an inventor or co-inventor of 16 issued US patents, and her work has been cited more than 7,000 times according to Google Scholar.

Dr. Xu liangliang is a professor at the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine. He obtained his PhD degree at the department of Orthopedics & Traumatology of the Chinese University of Hong Kong. He has published more than 48 articles related to stem cells and regenerative medicine (914 citations in total, H index 21) in journals including FASEB J, Stem cell research & therapy, SCI Rep, cell transplantation, Stem Cells Dev, Oncotarget, etc. He has been a reviewer of many journals such as Biomaterials, Acta Biomaterialia, Cell proliferation, Oncotarget, Cell death and diseases, etc. Besides, he is an associate board member of Current Proteomics journal.

John S. Yu is the Medical Director of the Brain Tumor Center at Cedars-Sinai Medical Center. He is Professor and Vice Chair in the Department of Neurosurgery. He is conducting research in immune and stem cell therapy for brain tumors. He is the founder and director of Immunocellular Therapeutics, a clinical stage public biotech company located in Calabasas, California. He earned his bachelor's degree from Stanford University and spent a year at the Sorbonne in Paris studying French literature. He completed his fellowship in immunology at the Institut Pasteur in Paris. He earned his medical degree from Harvard Medical School and master's degree from the Harvard University Department of Genetics.

Dr. Jane Ru Choi received her Ph.D. in Biomedical Engineering from University of Malaya, Malaysia in 2016. She is currently a Research Fellow at The University of British Columbia, Canada. Her research interests include cell and molecular biology, stem cell technologies, analytical chemistry, biomaterials and nanomaterials, and the development of microfluidic technologies for environmental monitoring, food safety analysis and a wide range of biomedical applications. Dr. Choi has authored more than 30 peer-reviewed articles, 8 patents. Some of her works have been highlighted in Elsevier’s Summer Chemistry Collection, X-MOL News, Wiley Materials Views and Advanced Science News.

Ying-Mei Feng is a Professor at Capital Medical University in Beijing, China. Currently, she is also the deputy director of the Science and Technology Department at Capital Medical University. She received her medical degree from Tian Jin Medical University in China. After three years of residency in Neurology, she went to Belgium to pursue research. She received her Ph.D. degree in Medical Science at Leuven University in Belgium in 2008. Her main research interest is to understand the pathogenesis of vascular complications in diabetes and cardiovascular disease. She has published more than 40 papers in peer-reviewed journals including Blood, Arteriosclerosis, Thrombosis and Vascular Biology and Stem Cells. She has been on the editorial board of Plos One and Current Stem Cell Research & Therapy and served as a guest editor for Stem Cell International and Current Gene Therapy, respectively.

Prof. Ahmed Hashash has completed his PhD from Manchester University, UK. He is a fellow of the California Institute of Regenerative Medicine (CIRM) and New York University Medical School (MSSM), USA. In 2016, Prof. Hashash joined The University of Edinburgh, Edinburgh Medical School-Zhejiang International Campus, (ZJU) as Tenure-Track Associate Professor and Senior Principal Investigator of Biomedicine, Stem Cell & Regenerative Medicine. He is also adjunct Professor at the School of Basic Medical Science and School of Medicine, Zhejiang University. He has published more than 34 papers in reputed international journals and serves as an editorial board member of several journals of repute. Prof. Hashash has received several international awards and recognitions over the years, including being the nominee for the prestigious One-Thousand talent project prize (Zhejiang, China), and Kuwait Foundation for the Advancement of Science’s (KFAS) Prize in Applied Medical Sciences, and Manchester University Fellowship Award (UK).

Dr. Neelesh Sharma graduated in Veterinary Science and post-graduated in Veterinary Medicine during the period of 2001 to 2003. Dr. Sharma focused on Stem cell based research in livestock during his Ph.D. from Jeju National University, South Korea; and is currently working as a Senior Assistant Professor in the Division of Veterinary Medicine, Faculty of Veterinary Science & Animal Husbandry, Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu, India. He has more than 13 years of experience in teaching, research and extension. He has been working on mastitis in dairy animals and authored a book on “Bovine Mastitis”. He has successfully isolated, characterized and established Korean Holstein cow mammary epithelial/stem cell lines.

Dr. Giovane Tortelote obtained PhD in Developmental and cell Biology. He has a large experience with culture of primary human cells, assays for pluripotency and differentiation of iPS cells. Dr. Tortelote has skills with mice development, kidney physiology and disease modeling. His present occupation is Education & Scientific Advisor at Strategic cooperate development & Scientific counseling for Medtech and Biotech companies aiming Australia and Latin America. He is also an Assistant Professor of Human Anatomy and Organ Physiology at Celso Lisboa University Center. He is also involved in the development and implementation a new digital platform to improve students’ learning capability.

Dr. Yang is a Research Faculty at the City College of New York. He received a B.S. degree in Mathematics from National Taiwan University, a M.S. degree in Mechanical Engineering from Columbia University and a Ph.D. degree in Biomedical Engineering from Georgia Institute of Technology. Before accepting the current faculty position, he was a postdoctoral researcher in the Center for Stem Cell and Regenerative Medicine at the University of Texas Health Science Center at Houston. The objective of Dr. Yang’s research is to develop innovative engineering technologies in order to create models that help understand the pathophysiology of disease and optimize bioprocessing strategies toward regeneration of human tissues. His research program focuses on stem cell engineering, stem cell aging, biomaterials, drug delivery, tissue engineering and regenerative medicine.

Isotta Chimenti is Researcher/Assistant Professor at the Department of Medical Surgical Sciences and Biotechnologies, and Junior Fellow of the Superior School for Advanced Studies at “La Sapienza” University of Rome. She is MS in Medical Biotechnology and PhD in Experimental Medicine. She has been a postdoc fellow at Johns Hopkins University, Cedars Sinai Heart Institute, and at Pasteur Institute – Italy. Her research activity is focused on cardiac cell therapy and cardiac tissue engineering, adult stem cells, mechano-sensing, and oxidative stress in the cardiovascular system. She is funded as PI by several Italian National grants, and participant in a European Horizon 2020 project. She has co-authored 50 Scopus indexed publications.

Dr. En-Qiang Chen has graduated from Sichuan University( Chengdu, China) and served as Associate professor in Center of Infectious Diseases, West China Hospital of Sichuan University. He has published more than 50 full peer reviewed publications, 8 book chapters, 15 presentations at international meetings, 2 peer reviewed funded grants and 1 authorized patent. In recent years, he has focused on the basic and clinical research of stem cells in the treatment of liver diseases.

Ying-Mei Feng is a Professor at Capital Medical University in Beijing, China. Currently, she is also the deputy director of the Science and Technology Department at Capital Medical University. She received her medical degree from Tian Jin Medical University in China. After three years of residency in Neurology, she went to Belgium to pursue research. She received her Ph.D. degree in Medical Science at Leuven University in Belgium in 2008. Her main research interest is to understand the pathogenesis of vascular complications in diabetes and cardiovascular disease. She has published more than 40 papers in peer-reviewed journals including Blood, Arteriosclerosis, Thrombosis and Vascular Biology and Stem Cells. She has been on the editorial board of Plos One and Current Stem Cell Research & Therapy and served as a guest editor for Stem Cell International and Current Gene Therapy, respectively.

Dr. Heedoo Lee is a professor at the Department of Biology and Chemistry in Changwon National University, Korea. His main research interest revolves around the biological/physiological function of extracellular vesicles (EVs) and non-coding RNAs in pulmonary diseases, including acute lung injury and acute respiratory distress syndrome and non-coding RNAs. In 2013, he got his PhD from Yonsei University, Korea with the support of BK21 PLUS (Brain Korea 21 Program for Leading Universities' Students), supported by the Korean government. During 2014 – 2019, he had postdoctoral training at Washington University in St. Louis, Brigham and Women's Hospital (affiliated with Harvard Medical School), and Boston University School of Medicine. During the past five years, his research led to publications in internationally renowned journals, including the Journal of Experimental Medicine, Journal of Immunology, American Journal of Physiology-Lung Cellular and Molecular Physiology, Scientific Reports, and Journal of Controlled Release.

Yonggang Lv received the Ph.D. degree in Refrigeration and Cryogenic Engineering with specialty in bioengineering from the Technical Institute of Physics and Chemistry, Chinese Academy of Science, Beijing, in 2005. He served as a postdoctoral research associate/research fellow at the City College of the City University of New York and Memorial Sloan-Kettering Cancer Center. He joined the Bioengineering College at Chongqing University as Full Professor in March 2009 and won the Program for New Century Excellent Talents in University, Ministry of Education of China in 2010. He became a senior visiting scholar in Prof. Shu Chien’s laboratory at University of California, San Diego (UCSD) from July to October 2014. He has published over 100 peer referred journal papers, edited 3 books, and holds 9 China patents. His research interests include mechanobiology and regenerative medicine, stem cell biology, and cancer biology. Dr. Lv is the Vice Chairman of hemorheology committee in Chinese Society of Microcirculation. He is an associate editor of Medical & Biological Engineering & Computing and an editorial member of Biotechnology Letters.

Dr. Hanieh Nokhbatolfoghahaei obtained her D.D.S (Doctor of Dental Surgery) degree from the Islamic Azad University, Dental Branch, Tehran, Iran, with the thesis entitled: "The effect of different treatment of teeth on tensile bond strength of composite artificial to acryl". Recently, in 2021, she received her PhD in Tissue Engineering from Shahid Beheshti University of Medical Sciences, Research Institute of Dental Sciences, Dental School, Tehran, Iran, with the dissertation entitled: "Fabrication of acellular functionalized scaffold for bone tissue engineering in maxillofacial region". Her research interests mainly focus on Regeneration Medicine, Bone Tissue Engineering, Bioreactors, 3D Cell Culture, 3D printing, Bioprinting, Lasers in Dentistry, Low Level Laser Therapy, Craniofacial Regeneration, and Dental/oral tissue-derived stem cells. So far she has published 32 manuscripts, 3 book chapters, and more than 50 conference papers. Dr. Nokhbatolfoghahaei has received a research grant in 2016 from the Ministry of Health and Medical Education, Tehran, Iran.

Dr. Yuping Wang did his Bachelors in Clinical Medicine from the Department of Clinical Medicine, Lanzhou Medical College, in 2000. Then, in 2004, he completed his Masters in Medicine from the Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Lanzhou Medical College. In 2011, Dr. Wang received his Ph.D. in Medical Science from Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, and carried out a study on Genetics. He is currently serving as an Associate Professor, Head of the Key Laboratory for Gastrointestinal Diseases of Gansu Province, Department of Gastroenterology, The First Hospital of Lanzhou University, China. Being an author / co-author, he has published over 50 manuscripts in various reputable journals.

Prof Junjie XIAO is the Director of Institute of Cardiovascular Sciences in Shanghai University and the Vice Dean of School of Life Sciences, Shanghai University. He is the Associate Editor of Journal of Cardiovascular Translational Research, Editorial Board of BMC Medicine, and Editorial Board of Cell Transplantation. His major research interest is heart failure, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating heart failure.

Dr. Leisheng Zhang obtained his bachelor's degree in Veterinary Medicine from College of Animal Husbandry and Veterinary medicine, Jilin University, in 2007. Then he earned his Ph.D. degree in Cell Biology from the Peking Union Medical College & Chinese Academy of Medical Sciences (Faculty of Medicine, Tsinghua University), Institute of Hematology & Blood Diseases Hospital, in 2012. He was engaged in postdoctoral research in Cell Biology at the School of Medicine, Nankai University, in 2018. His research interests mainly focus on the biological function and molecular mechanism of mesenchymal stem/stromal cells (MSCs), including early development from human pluripotent stem cells (hPSCs), cellular phenotype and genomic analysis, and applied transformation research.